1. Home
  2. Knowledge Base
  3. References
  4. Memory and cholinergic impairment using a new approach of bilateral lesion of rat cholinergic basal forebrain

Memory and cholinergic impairment using a new approach of bilateral lesion of rat cholinergic basal forebrain

Manuel I, Llorente A, Gonzalez de San Roman E, Merino L, Giralt M, Rodriguez-Puertas R (2014) Memory and cholinergic impairment using a new approach of bilateral lesion of rat cholinergic basal forebrain. Neuroscience 2014 Abstracts 134.02. Society for Neuroscience, Washington, DC.

Summary: The cholinergic basal forebrain neurons (CBFN), which innervate cortical, hippocampal and amygdaloid areas control learning and memory processes and are damaged in Alzheimer´s disease (AD). The aim of the present study was to characterize the model of selective induced CBFN death in the nucleus basalis of Meynert (nbM) of adult Sprague-Dawley rats by intraparenquimal injection of the specific CBFN immunotoxin 192IgG-saporin (SAP) (n=11; 1μl/side [135ng/μl]). Learning and memory behavior was evaluated with the passive avoidance (PA) test. The CBFN density and the presence of glial cells were evaluated by immunofluorescence (P75NTR, Neu-N, GFAP, Iba-1). The AChE activity and AChE+ neuron density were analyzed by staining reaction. A significant decrease in CBFN (P75NTR -ir) density was observed in SAP treated rats (-82,7% vs aCSF, p<0,001). We found that cognitive impairment in the PA test and the reduction in the CBFN density in nbM correlated with each other (P75NTR+-ir vs PA, r2=0,51, p<0,05). Similar results were obtained for the reduction in AChE staining in cortical areas (entorhinal cortex: r2=0,55, p<0,01), hippocampus (CA3 pyramidal: r2=0,49, p<0,01) and amygdala (anterior: r2=0,43, p<0,01). Immunofluorescence studies showed a high density of activated microglia (Iba-1-ir) and an abscence of astrocytes (GFAP-ir) in the SAP administration area. Moreover, using MALDI-IMS assay, some lipid species were modified around the lesion area in SAP treated rats. The obtained data on the above described model of CBFN death, mimics the cognitive and cholinergic system impairment described in AD patients.

Related Products: 192-IgG-SAP (Cat. #IT-01)